ibrutinib,zanubrutinib
abbvie,beigene,janssen
['brukinsa', 'zanubrutinib', 'imbruvica', 'cll', ' ibru', 'alpine']
#ash22 breaking update: listen as dr. tara graff discusses the alpine trial which shows how zanubrutinib (brukinsa) outperforms ibrutinib (imbruvica) in r/r #cll. "you re getting 2 benefits: less aes and better outcomes in terms of efficacy. #medtwitter 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.